Your browser doesn't support javascript.
loading
Antineoplastic agents exacerbating Charcot Marie Tooth disease: red flags to avoid permanent disability.
Ibañez-Juliá, M J; Berzero, G; Reyes-Botero, G; Maisonobe, T; Lenglet, T; Slim, M; Louis, S; Balaguer, A; Sanson, M; Le Guern, E; Latour, P; Ricard, D; Stojkovic, T; Psimaras, D.
Affiliation
  • Ibañez-Juliá MJ; a Department of Neurology Mazarin , Hôpitaux universitaires Pitié-Salpêtrière Charles Foix. Assistance Publique Hôpitaux de Paris (APHP) , Paris , France.
  • Berzero G; b Neuroscience Consortium, University of Pavia , Monza Policlinico and Pavia Mondino , Pavia , Italy.
  • Reyes-Botero G; c Cancer Unit, Neuro-oncology Section, Hospital Pablo Tobón Uribe , Medellín, Colombia.
  • Maisonobe T; d Department of Clinical Neurophysiology , Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix. Assistance Publique Hôpitaux de Paris (APHP) , Paris , France.
  • Lenglet T; e OncoNeuroTox Group: Center for Patients with Neurological Complications of Oncologic Treatments, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix et Hôpital d'Instruction des Armées Percy , Paris and Clamart , France.
  • Slim M; d Department of Clinical Neurophysiology , Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix. Assistance Publique Hôpitaux de Paris (APHP) , Paris , France.
  • Louis S; e OncoNeuroTox Group: Center for Patients with Neurological Complications of Oncologic Treatments, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix et Hôpital d'Instruction des Armées Percy , Paris and Clamart , France.
  • Balaguer A; e OncoNeuroTox Group: Center for Patients with Neurological Complications of Oncologic Treatments, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix et Hôpital d'Instruction des Armées Percy , Paris and Clamart , France.
  • Sanson M; f Department of Oncology , Hôpitaux universitaires Pitié-Salpêtrière Charles Foix. Assistance Publique Hôpitaux de Paris (APHP) , Paris , France.
  • Le Guern E; g Department of Neurology Mazarin , Institute of Myology, Hôpitaux universitaires Pitié-Salpêtrière Charles Foix. Assistance Publique Hôpitaux de Paris (APHP) , Paris , France.
  • Latour P; h Department of Hematology , Hospital Universitario y Politécnico La Fe , Valencia , Spain.
  • Ricard D; a Department of Neurology Mazarin , Hôpitaux universitaires Pitié-Salpêtrière Charles Foix. Assistance Publique Hôpitaux de Paris (APHP) , Paris , France.
  • Stojkovic T; i Inserm U 1127, CNRS UMR 7225, Sorbonne Université , France.
  • Psimaras D; j Department of Genetics , Hôpitaux universitaires Pitié-Salpêtrière Charles Foix. Assistance Publique Hôpitaux de Paris (APHP) , Paris , France.
Acta Oncol ; 57(3): 403-411, 2018 Mar.
Article in En | MEDLINE | ID: mdl-29243538

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Charcot-Marie-Tooth Disease / Neoplasms / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Francia Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Charcot-Marie-Tooth Disease / Neoplasms / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Francia Country of publication: Reino Unido